|
HS Code |
481838 |
| Chemical Name | Adenosine Triphosphate |
| Abbreviation | ATP |
| Molecular Formula | C10H16N5O13P3 |
| Molar Mass | 507.18 g/mol |
| Appearance | White crystalline solid |
| Solubility In Water | Highly soluble |
| Melting Point | Decomposes before melting |
| Biological Role | Primary energy carrier in cells |
| Cas Number | 56-65-5 |
| Storage Conditions | Store at -20°C, protected from light and moisture |
As an accredited Adenosine Triphosphate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | A sealed amber glass vial containing 500 mg Adenosine Triphosphate powder, labeled with batch number, expiry date, and safety warnings. |
| Shipping | Adenosine Triphosphate (ATP) should be shipped in a cold, insulated container with dry ice or ice packs to maintain stability. Use leak-proof, clearly labeled packaging. Avoid exposure to heat, moisture, or direct sunlight. Follow all applicable chemical transport regulations, and include the material safety data sheet (MSDS) with the shipment. |
| Storage | Adenosine Triphosphate (ATP) should be stored dry, protected from light, at –20°C or below to prevent degradation. ATP solutions are typically aliquoted and kept at –20°C, avoiding repeated freeze-thaw cycles. For short-term use, solutions can be stored at 4°C for a few days. Ensure containers are tightly sealed to avoid moisture and maintain stability. |
|
Purity 99%: Adenosine Triphosphate with purity 99% is used in molecular biology assays, where it ensures high signal fidelity in enzymatic reactions. Molecular Weight 507.18 g/mol: Adenosine Triphosphate with molecular weight 507.18 g/mol is used in cell culture media, where it promotes optimal energy transfer for cellular proliferation. Stability Temperature -20°C: Adenosine Triphosphate with stability temperature -20°C is used in biochemical storage solutions, where it maintains enzymatic activity during long-term storage. Lyophilized Powder Form: Adenosine Triphosphate in lyophilized powder form is used in diagnostic kits, where it allows rapid reconstitution for immediate use in ATP-dependent assays. pH Range 7.0-7.4: Adenosine Triphosphate at pH range 7.0-7.4 is used in enzyme kinetics studies, where it provides consistent reaction conditions for reliable kinetic measurements. Solubility 100 mg/mL (water): Adenosine Triphosphate with solubility 100 mg/mL in water is used in intravenous nutrition solutions, where it facilitates efficient cellular uptake and energy metabolism. Endotoxin Level <0.1 EU/mg: Adenosine Triphosphate with endotoxin level less than 0.1 EU/mg is used in pharmaceutical manufacturing, where it minimizes immunogenic response in parenteral therapies. Particle Size < 10 microns: Adenosine Triphosphate with particle size less than 10 microns is used in pharmaceutical formulations, where it enables uniform dispersion and rapid dissolution. |
Competitive Adenosine Triphosphate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Everyday work in a chemical manufacturing plant keeps us close to the processes that bring Adenosine Triphosphate, or ATP, out of theory and into the bottles, vials, and bulk containers going to customers worldwide. Each batch we produce represents a complex chain of careful sourcing, precision synthesis, steady monitoring, and continual trailblazing in purity and stability. ATP anchors the biochemical labor in so many labs and production lines—whether in cell culture studies, clinical diagnostic kits, or enzymatic synthesis—because this molecule wears many hats. In the lab and on the factory floor, it powers everything from kinase screening assays to luciferase-based ATP detection, making it indispensable for research and diagnostics.
When we talk about ATP, we’re not dealing in abstract chemistry. We’re solving daily challenges: keeping purity at or above 99%, ensuring batch-to-batch consistency, extending shelf-life with robust lyophilization, maintaining true sodium or magnesium salt forms, and avoiding contaminating nucleotides or breakdown products. Once researchers open a vial from one of our shipments, we want them to trust the readings on their plate readers or chromatographs without worrying about hidden impurities. That trust depends on robust, transparent upstream manufacturing, rigorous quality checks, and a hands-on sense of responsibility at every stage. Not every source of ATP can make this same guarantee, and our history in producing high-purity nucleotides has taught us just how much impact a seemingly tiny difference can make.
ATP comes in multiple presentations, and the right format makes a real difference in end-use success. The most frequently requested model in our line-up has a molecular formula of C10H16N5O13P3 and a molar mass near 507.18 g/mol in its basic form. For most life science applications, we focus on the sodium salt and magnesium salt variants, with sodium ATP (disodium salt, hydrate) commanding steady interest from biochemistry labs. Researchers using ATP in enzymatic or cell signaling assays depend on sodium and magnesium salts for maximum solubility and biological compatibility. Every lot coming from our plant is tested for solubility (in water, above 50 mg/mL for sodium salt) and subjected to HPLC and NMR assessment.
We never lose sight of the importance of specification details like UV purity (at λ260/λ280), residual water content, heavy metal traces, and bacterial endotoxins. A high UV absorbance ratio signals a clean nucleotide, while strict water control keeps the product shelf-stable. Our lyophilization process produces a fine, white powder—free-flowing, easy to aliquot, and quick to dissolve, reducing handling time for busy lab workers. Lyophilized ATP in glass vials, sealed under inert atmosphere, avoids early hydrolysis and extends the usable life of the product, a challenge every supplier faces and only a few solve dependably.
Because ATP is unstable outside controlled environments, especially in solution, timing and conditions count for everything. For shipment, we rely on insulated containers and temperature loggers if climatic risks threaten to degrade product quality. Manufacturing protocols demand daily checks of storage temperatures, with real-time deviation alerts sent directly to our production leads. From the first synthesis steps to labeling, strict protocols clamp down on contamination risks—not just for regulatory compliance, but for our own peace of mind, having seen how minor lapses compromise experimental data.
Direct manufacturing experience teaches the burdens and lessons nobody else faces. While some ATP on the market comes from brokers or repackagers cobbling together bulk powder from multiple origins, we keep control within our own facilities. This means traceable raw materials, transparent production records, audited cleaning protocols, and a single unbroken chain of custody. Our process puts every batch through warrantied analytical steps. Chromatogram fingerprinting, moisture content assessment, and biological contamination screening happen as part of the job, not just as a formality. In-house synthesis and finishing—rather than buying from third parties—lets us catch, troubleshoot, and fix inconsistencies at their root.
That difference becomes visible in several ways: fewer customer complaints about batch inconsistencies, more reproducible results in independent quality control, and a lower incidence of false positives in sensitive detection assays. Researchers running luminescent ATP-detection systems in environmental or food testing will notice fewer false negatives with our batches due to lower background contamination. Drug development labs running high-throughput kinase assays see reduced variance, saving resources on retesting. These outcomes stem not from marketing language, but from boots-on-the-ground focus from our QC and production teams who have watched other products fail and know what it costs their colleagues in lost time.
Making and supplying ATP should never be approached like selling a commodity. Each step brings challenges: hydrolysis risks, temperature sensitivity, exposure to light, and the constant threat of adventitious contamination. In hot or humid climates, ATP risks rapid breakdown, turning high-purity nucleotide into a mess of ADP, AMP, and inorganic phosphate. We install positive pressure rooms and ultra-low humidity dehumidification systems to block atmospheric moisture from reaching product in process, investing in infrastructure that only manufacturers see the true value of.
Our cleanroom workers track powdered ATP through microbalance weighing with regular calibration checks. In-line rapid microbial testing joins more traditional plating, since slowdowns can ruin entire batches. We train staff in contamination control because no amount of downstream processing can polish away issues that start upstream. Bulk-scale synthesis brings up handling headaches: static, clumping, and transfer losses all eat into yield and increase costs if left unchecked. Real-world manufacturing is about fixing these headaches, not just reading about them.
Once ATP leaves our warehouse, our engineers and chemists stay in touch with users. We field regular requests for usage advice from researchers troubleshooting unexpected assay results or fighting solubility problems. Sometimes it’s a question of buffer incompatibility; sometimes it’s unintended temperature excursions during storage or shipping. Real feedback loops from experienced customers help us fine-tune our process, bringing actual application data back into plant-level decision making.
Supply chain issues present another real-world concern. Raw material delays, transport bottlenecks, and unpredictable regulatory checks challenge us to keep stocks ahead and pathways clear. We overstock raw purine bases and phosphate reagents to hedge against international transport slowdowns. Plant managers follow up personally with logistics partners during periods of political or climatic disruption. These habits mean fewer surprises for regular buyers who return to us year over year.
Not every customer needs the same format or volume. Educational labs, biotech start-ups, and established pharmaceutical giants each have their own standards and workflow quirks. Our decades on the manufacturing side give us a practical sense for which format—sodium salt, magnesium salt, freeze-dried, or in solution—truly works best in a given context. We explain the trade-offs directly, drawing on root-cause analysis from past incidents. We know from repeated experience the fine points that separate a batch that dissolves cleanly, stores well, and runs trouble-free, from one that clumps, degrades, or impacts lab results.
In the chemical industry, purity metrics sometimes get touted as a box-checking exercise, but for ATP, they matter every day at the bench. Any contaminant, be it residual solvent, heavy metal, or breakdown nucleotide, risks fouling enzyme kinetics, corrupting energy transfer studies, or undermining PCR amplification. We hold purity to a minimum 99% by HPLC—but field real questions on batch-to-batch trace element fluctuation and storage artifact formation. Documented impurity profiles minimize laboratory surprises: an unexplained drop in signal, a noisy background, a run that failed without a clear culprit.
Stability drives decisions surrounding formulation and packaging. ATP solutions, unless frozen, degrade with alarming speed, so we steer customers toward lyophilized powder and freshly made solutions for sensitive work. Our own process engineering research concentrates on extending shelf life through advanced lyophilization and careful protection from humidity. Vials with inert gas overlay and light-blocking wraps counteract photodegradation. If an improvement surfaces that bumps up real-world shelf life or cuts post-delivery incidents, we implement it, tracking every customer report and internal test toward continual product reliability.
Customer labs sometimes need specific formulations—calcium complex, alternate buffers, low endotoxin, or chemically defined grades. Our production team brooks no shortcuts: each new variant gets full analytical validation, microbiological screening, and stability testing. Hard-won lessons from manufacturing failures in our own or peer factories put us on alert for even rare forms of cross-contamination or lot-to-lot drift.
Not every nucleotide analog can fill the same roles as ATP. In the world of biochemistry, ATP stands out as a universal energy donor across biological kingdoms. Its triple-phosphate structure supports direct phosphorylation, cell signaling, and bioluminescent detection in ways that GTP, CTP, or UTP cannot always match. Our lab teams, working side by side with customer development scientists, continually run side-by-side comparison studies to document performance differences. These real tests—competitor samples run on the same assays, platforms, and personnel—shine a light on weak spots only a manufacturer confronts.
Some users argue that recombinant enzymatic synthesis or alternative nucleotide analogs reduce dependency on high-purity ATP, but many workflows still fail without direct ATP input. For instance, luciferase-based reaction systems for rapid contamination testing in food safety depend on ATP as the only viable energy donor. ATP analogs might show up on data sheets, but when tested in live systems, they rarely outperform well-manufactured ATP. And poorly purified ATP, especially from discount sources, causes more trouble than it solves: delayed experiments, false assay failures, wasted reagents, and reworked protocols. That awareness shapes how we educate buyers assessing substitutes or making cost-based cuts.
We’ve learned from repeated user feedback that ATP’s solubility (quick, complete, residue-free) trumps most analogs, vital for high-throughput screening where dead time is costly. ATP’s heat and pH instability remain challenges, but our care in packaging and buffering counters these for typical usage times. Substitution with ADP or AMP fails outright in phosphorylation studies, kinase-driven reactions, or molecular motor research. These are hard facts, tested and retested across workflows.
Most chemicals suppliers focus on supply and cost, but as primary manufacturers, we see the full arc: from raw material price shocks and regulatory hurdles to field complaints landing on our technical lines. We answer questions from quality control technicians, troubleshooters, and lab managers—and bring their real-world verifications back to process improvements. The expectation isn’t just “good enough for most uses,” but “trouble-free and reproducible every cycle.” Achieving that standard means sweat on the manufacturing floor, conscious choices at every step, and never letting up on training or system upgrades.
As national and international standards for biochemical reagents grow tighter, we keep pace by investing in new process analytical technology, better bioburden controls, and more precise batch documentation. We pass along manufacturing insights—temperature risks, incomplete dissolution, shelf life tradeoffs—to make users’ jobs smoother. We invite and rely on constructive criticism, knowing that user issues drive real-world improvement: every failed run or equipment alarm might uncover a corner not yet seen.
Our outreach includes technical documentation, seminars, and customized trainings for ATP users tackling unusual projects or scaling up to pilot production. Discussion with research groups, diagnostic kit designers, and pharmaceutical QA engineers feeds directly into our own development. We keep a feedback loop running between manufacturing realities and final user needs, closing gaps between theory and lab bench.
Supply continuity matters as much as molecular detail. During tight market periods—raw material shortages, production outages, or logistics snarls—we hold buffers and flex production schedules to fulfill standing orders. This isn't marketing language but hard-learned certainty: reliability is earned by advance planning, investment, and active management, not after-the-fact apologies. We built redundancies into our purification systems and storage capabilities, learn from global incidents, and keep pace with growing demand by scaling up before it's too late.
The landscape for ATP and its parent nucleotides is evolving, driven by expanded biopharma work, new diagnostic technologies, and increased regulatory oversight. We keep an eye on green chemistry trends—lower environmental impact, energy-efficient synthesis routes, tighter water management. Our plant upgrades include solvent recovery, energy monitoring, and waste minimization, balancing the demands for scale with real accountability. Traceability, down to the lot-level tracking and on-demand documentation, stays front-and-center.
We see suppliers under pressure to prove ethical sourcing, low environmental impact, and transparent origin as scrutiny grows. Our response is direct engagement with suppliers, demanding documentation and third-party verification for raw materials. Internally, we push for energy audits and water use minimization. Making ATP sustainably not only keeps us ready for the next certification or compliance step, but builds trust with every client concerned about environmental and social governance.
Every process change, upgrade, or logistic reroute gets recorded, assessed, and fed back into operational protocols. We see manufacturing as a continual learning exercise, where each improvement stems from real feedback—customer field trials, new regulatory benchmarks, and equipment innovations. That’s why the ATP leaving our gates is not just a chemical, but the sum of decades of manufacturing know-how and user-centered development.
Life science’s appetite for ATP is growing—multiplexed assays, new diagnostic formats, and ever-higher demands for reproducibility. Keeping pace pushes us toward constant incremental improvements, balancing purity, stability, packing innovation, and responsible sourcing.
Each time someone dissolves a vial for a kinase assay, powers a bioluminescence reaction in a diagnostic kit, or screens drug leads in a pharmacological study, they’re relying not on supply-chain magic, but on the painstaking, hands-on discipline of our manufacturing crew. Our commitment grows with every batch, shipment, and customer story—linking real-world feedback to safer, more reliable ATP for labs worldwide.
Adenosine Triphosphate isn’t just another product line, and producing it means more than hitting a purity spec or beating a price target. It’s about honoring the scientific endeavor by returning the very best product, with traceable quality, continual improvements, and open dialogue between those who make it and those who use it. That mindset, shaped by every day spent on the production floor, drives our insistence on standards and our pride in every shipment that bears our name.